Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Insulin experiment sheds light on fatty liver mystery

NCT ID NCT05724134

First seen Jan 04, 2026 · Last updated Jun 15, 2026 · Updated 29 times

Summary

This study looked at how different levels of insulin affect blood sugar in people with fatty liver disease, obesity, and insulin resistance. 18 adults took part in two sessions where their insulin was carefully controlled. The goal was to understand the link between high insulin and fatty liver, not to test a new treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for OBESITY are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Columbia University Irving Medical Center

    New York, New York, 10032, United States

Conditions

The condition(s) this trial relates to.

diabetes mellitus hyperinsulinism Insulin Resistance metabolic dysfunction-associated steatotic liver disease Obesity prediabetes syndrome

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.